Mangini Siobhan Nolan

Insider Reports History

Location
C/O Nmg Biopharmaceuticals, Inc., 333 Oyster Point Blvd., South San Francisco, CA
Signature
/s/ John A. Mikowski, Deputy General Counsel and Assistant Corporate Secretary, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mangini Siobhan Nolan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alight, Inc. / Delaware Director Class A Common Stock 62.6K $351K $5.61 Jul 2, 2025 Direct
NGM BIOPHARMACEUTICALS INC President and CFO Common Stock 76K $102K $1.34 Mar 2, 2023 Direct
NGM BIOPHARMACEUTICALS INC President and CFO Stock Option (Right to Buy) 200K Mar 2, 2023 Direct

Insider Reports Filed by Mangini Siobhan Nolan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALIT Alight, Inc. / Delaware Jul 2, 2025 1 $0 4 Jul 7, 2025 Director
ALIT Alight, Inc. / Delaware Jan 15, 2025 1 $0 4 Jan 17, 2025 Director
ALIT Alight, Inc. / Delaware Jan 2, 2024 1 $0 4 Jan 3, 2024 Director
ALIT Alight, Inc. / Delaware Jan 1, 2024 0 $0 3 Jan 3, 2024 Director
NGM NGM BIOPHARMACEUTICALS INC Mar 2, 2023 3 $0 4 Mar 6, 2023 President and CFO
NGM NGM BIOPHARMACEUTICALS INC Jul 1, 2022 1 $0 4 Jul 1, 2022 President and CFO
NGM NGM BIOPHARMACEUTICALS INC Mar 3, 2022 1 $0 4 Mar 4, 2022 Chief Financial Officer